Anthropic's Claude Discovers Crispr-Like Enzyme System — SkimNews
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- Anthropic says Claude autonomously discovered a previously uncharacterized enzyme system in bacteriophages, calling it similar to machinery behind Crispr and calling it the first result from its newly-launched wet lab.
- The search ran nearly 950 Claude agents for 21 hours and consumed 210 million tokens before one agent flagged an unusual repeating pattern in a massive DNA sequence database for human review.
- Anthropic said its scientists' involvement was limited to the initial prompt and subsequent lab testing, and that the company wanted to share findings early to demonstrate Claude's capabilities and give the community insight into its work.
- Despite the Crispr comparison, practical applications of the enzyme system remain unclear, and Anthropic is still working to understand what it does.
- The announcement comes as Anthropic prepares to go public, seeks to attract more scientists to its lab, and expands into areas like drug discovery.
- The move reflects AI companies turning to scientific research to prove model value, while OpenAI has been barreling through advanced mathematical problems with little regard for academic norms.
Why it matters: Anthropic itself calls the announcement 'admittedly premature,' and the source notes practical applications are unknown — making this less a scientific breakthrough than a capability demo timed to Anthropic's IPO plans and its bid to recruit scientists for a drug-discovery push. The Crispr framing is Anthropic's own PR scaffolding for a wet lab's first output, not evidence of a comparable discovery.
Ask SkimNews
